New Delhi, Sep. 18 (PTI): Three of the nearly 30 coronavirus vaccine candidates in the country are in advanced stages of clinical trials, while four...

New Delhi, Sep. 16 (PTI): Drugs Controller General of India (DCGI) Dr V G Somani has gave permission to Serum Institute of India to resume...

New Delhi, Sept. 16 (PTI): The government on Wednesday said more than 30 vaccine candidates for coronavirus have been supported, and three of them are...

New Delhi, Sep 11 (IANS): Amid the raging coronavirus pandemic, PNB Vesper Life Science Private Limited on Friday received approval from the Drug Controller General...

New Delhi, Sep. 10 (IANS):The Serum Institute of India (SII), which was conducting the India trials for the coronavirus vaccine being developed by Oxford University,...

New Delhi, Sep. 10 (IANS): Pharma major AstraZeneca has said it is working to expedite the review of the single event to minimise any potential...

London, Sep. 9 (PTI): The human trials of one of the most promising Covid-19 vaccine candidates, being developed by the University of Oxford, has been...

New Delhi, Sep. 9 (IANS): The clinical trials of Oxford vaccine will continue in India as usual as it has faced no issue at all,...